APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Normal Immunoglobulin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Human Normal Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchHuman Normal Immunoglobulin Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Normal Immunoglobulin Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Human Normal Immunoglobulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Normal Immunoglobulin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Normal Immunoglobulin Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Normal Immunoglobulin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Human Normal Immunoglobulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Normal Immunoglobulin include ADMA Biologics, Biotest, CBPO, CNBG, CSL Behring, Emergent (Cangene), Grifols, Kamada and Kedrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Human Normal Immunoglobulin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Human Normal Immunoglobulin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Human Normal Immunoglobulin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Human Normal Immunoglobulin market size, projected growth trends, production technologies, key applications, and end-use industries.

Human Normal Immunoglobulin Segment by Company

ADMA Biologics

Biotest

CBPO

CNBG

CSL Behring

Emergent (Cangene)

Grifols

Kamada

Kedrion

Hualan Bio

Shanghai RAAS

Sichuan Yuanda Shuyang

Human Normal Immunoglobulin Segment by Type

Hepatitis B Immunoglobulins

Tetanus Immunoglobulins

Rabies Immunoglobulins

Others

Human Normal Immunoglobulin Segment by Application

Government Institutions

Private Sector

Other

Human Normal Immunoglobulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Normal Immunoglobulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Normal Immunoglobulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Normal Immunoglobulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Human Normal Immunoglobulin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Normal Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Human Normal Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Human Normal Immunoglobulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Human Normal Immunoglobulin Industry Trends Table 2. Human Normal Immunoglobulin Industry Drivers Table 3. Human Normal Immunoglobulin Industry Opportunities and Challenges Table 4. Human Normal Immunoglobulin Industry Restraints Table 5. Global Human Normal Immunoglobulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Human Normal Immunoglobulin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Human Normal Immunoglobulin Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Human Normal Immunoglobulin Sales Market Share by Manufacturers Table 9. Global Human Normal Immunoglobulin Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Human Normal Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Human Normal Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Human Normal Immunoglobulin Manufacturers, Product Type & Application Table 13. Global Human Normal Immunoglobulin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Human Normal Immunoglobulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hepatitis B Immunoglobulins Table 17. Major Manufacturers of Tetanus Immunoglobulins Table 18. Major Manufacturers of Rabies Immunoglobulins Table 19. Major Manufacturers of Others Table 20. Global Human Normal Immunoglobulin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Human Normal Immunoglobulin Sales by Type (2021-2026) & (K Units) Table 22. Global Human Normal Immunoglobulin Sales by Type (2027-2032) & (K Units) Table 23. Global Human Normal Immunoglobulin Sales Market Share by Type (2021-2026) Table 24. Global Human Normal Immunoglobulin Sales Market Share by Type (2027-2032) Table 25. Global Human Normal Immunoglobulin Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Human Normal Immunoglobulin Revenue by Type (2021-2026) & (K Units) Table 27. Global Human Normal Immunoglobulin Revenue by Type (2027-2032) & (K Units) Table 28. Global Human Normal Immunoglobulin Revenue Market Share by Type (2021-2026) Table 29. Global Human Normal Immunoglobulin Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Government Institutions Table 31. Major Manufacturers of Private Sector Table 32. Major Manufacturers of Other Table 33. Global Human Normal Immunoglobulin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Human Normal Immunoglobulin Sales by Application (2021-2026) & (K Units) Table 35. Global Human Normal Immunoglobulin Sales by Application (2027-2032) & (K Units) Table 36. Global Human Normal Immunoglobulin Sales Market Share by Application (2021-2026) Table 37. Global Human Normal Immunoglobulin Sales Market Share by Application (2027-2032) Table 38. Global Human Normal Immunoglobulin Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Human Normal Immunoglobulin Revenue by Application (2021-2026) & (K Units) Table 40. Global Human Normal Immunoglobulin Revenue by Application (2027-2032) & (K Units) Table 41. Global Human Normal Immunoglobulin Revenue Market Share by Application (2021-2026) Table 42. Global Human Normal Immunoglobulin Revenue Market Share by Application (2027-2032) Table 43. Global Human Normal Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Human Normal Immunoglobulin Sales by Region (2021-2026) & (K Units) Table 45. Global Human Normal Immunoglobulin Sales Market Share by Region (2021-2026) Table 46. Global Human Normal Immunoglobulin Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Human Normal Immunoglobulin Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 50. North America Human Normal Immunoglobulin Sales by Country (2027-2032) & (K Units) Table 51. Europe Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 53. Europe Human Normal Immunoglobulin Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Human Normal Immunoglobulin Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Human Normal Immunoglobulin Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Human Normal Immunoglobulin Sales by Country (2027-2032) & (K Units) Table 60. Global Human Normal Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Human Normal Immunoglobulin Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Human Normal Immunoglobulin Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Human Normal Immunoglobulin Revenue Market Share by Region (2021-2026) Table 64. Global Human Normal Immunoglobulin Revenue Market Share by Region (2027-2032) Table 65. ADMA Biologics Company Information Table 66. ADMA Biologics Business Overview Table 67. ADMA Biologics Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ADMA Biologics Human Normal Immunoglobulin Product Portfolio Table 69. ADMA Biologics Recent Development Table 70. Biotest Company Information Table 71. Biotest Business Overview Table 72. Biotest Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Biotest Human Normal Immunoglobulin Product Portfolio Table 74. Biotest Recent Development Table 75. CBPO Company Information Table 76. CBPO Business Overview Table 77. CBPO Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. CBPO Human Normal Immunoglobulin Product Portfolio Table 79. CBPO Recent Development Table 80. CNBG Company Information Table 81. CNBG Business Overview Table 82. CNBG Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. CNBG Human Normal Immunoglobulin Product Portfolio Table 84. CNBG Recent Development Table 85. CSL Behring Company Information Table 86. CSL Behring Business Overview Table 87. CSL Behring Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. CSL Behring Human Normal Immunoglobulin Product Portfolio Table 89. CSL Behring Recent Development Table 90. Emergent (Cangene) Company Information Table 91. Emergent (Cangene) Business Overview Table 92. Emergent (Cangene) Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Emergent (Cangene) Human Normal Immunoglobulin Product Portfolio Table 94. Emergent (Cangene) Recent Development Table 95. Grifols Company Information Table 96. Grifols Business Overview Table 97. Grifols Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Grifols Human Normal Immunoglobulin Product Portfolio Table 99. Grifols Recent Development Table 100. Kamada Company Information Table 101. Kamada Business Overview Table 102. Kamada Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Kamada Human Normal Immunoglobulin Product Portfolio Table 104. Kamada Recent Development Table 105. Kedrion Company Information Table 106. Kedrion Business Overview Table 107. Kedrion Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Kedrion Human Normal Immunoglobulin Product Portfolio Table 109. Kedrion Recent Development Table 110. Hualan Bio Company Information Table 111. Hualan Bio Business Overview Table 112. Hualan Bio Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Hualan Bio Human Normal Immunoglobulin Product Portfolio Table 114. Hualan Bio Recent Development Table 115. Shanghai RAAS Company Information Table 116. Shanghai RAAS Business Overview Table 117. Shanghai RAAS Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Shanghai RAAS Human Normal Immunoglobulin Product Portfolio Table 119. Shanghai RAAS Recent Development Table 120. Sichuan Yuanda Shuyang Company Information Table 121. Sichuan Yuanda Shuyang Business Overview Table 122. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Portfolio Table 124. Sichuan Yuanda Shuyang Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Human Normal Immunoglobulin Distributors List Table 128. Human Normal Immunoglobulin Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Human Normal Immunoglobulin Product Image Figure 2. Global Human Normal Immunoglobulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Normal Immunoglobulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Normal Immunoglobulin Sales (2021-2032) & (K Units) Figure 5. Global Human Normal Immunoglobulin Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Human Normal Immunoglobulin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hepatitis B Immunoglobulins Image Figure 9. Tetanus Immunoglobulins Image Figure 10. Rabies Immunoglobulins Image Figure 11. Others Image Figure 12. Global Human Normal Immunoglobulin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Human Normal Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Human Normal Immunoglobulin Sales Market Share by Type (2021-2032) Figure 15. Global Human Normal Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Human Normal Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Human Normal Immunoglobulin Revenue Market Share by Type (2021-2032) Figure 18. Government Institutions Image Figure 19. Private Sector Image Figure 20. Other Image Figure 21. Global Human Normal Immunoglobulin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Human Normal Immunoglobulin Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Human Normal Immunoglobulin Sales Market Share by Application (2021-2032) Figure 24. Global Human Normal Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Human Normal Immunoglobulin Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Human Normal Immunoglobulin Revenue Market Share by Application (2021-2032) Figure 27. North America Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Human Normal Immunoglobulin Sales Market Share by Country (2021-2032) Figure 29. U.S. Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Human Normal Immunoglobulin Sales Market Share by Country (2021-2032) Figure 34. Germany Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Human Normal Immunoglobulin Sales Market Share by Country (2021-2032) Figure 41. China Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Country (2021-2032) Figure 49. Brazil Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Human Normal Immunoglobulin Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Human Normal Immunoglobulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Human Normal Immunoglobulin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Human Normal Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 60. North America Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Human Normal Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 62. Europe Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Human Normal Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Human Normal Immunoglobulin Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Human Normal Immunoglobulin Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Normal Immunoglobulin Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Immunoglobulins
  • Tetanus Immunoglobulins
  • Rabies Immunoglobulins
  • Others
Applications
  • Government Institutions
  • Private Sector
  • Other
Companies covered
  • ADMA Biologics
  • Biotest
  • CBPO
  • CNBG
  • CSL Behring
  • Emergent (Cangene)
  • Grifols
  • Kamada
  • Kedrion
  • Hualan Bio
  • Shanghai RAAS
  • Sichuan Yuanda Shuyang

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Human Normal Immunoglobulin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Human Normal Immunoglobulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Human Normal Immunoglobulin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Human Normal Immunoglobulin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Human Normal Immunoglobulin Market Dynamics
  1. 2.1 Human Normal Immunoglobulin Industry Trends
  2. 2.2 Human Normal Immunoglobulin Industry Drivers
  3. 2.3 Human Normal Immunoglobulin Industry Opportunities and Challenges
  4. 2.4 Human Normal Immunoglobulin Industry Restraints
3 Human Normal Immunoglobulin Market by Manufacturers
  1. 3.1 Global Human Normal Immunoglobulin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Human Normal Immunoglobulin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Human Normal Immunoglobulin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Human Normal Immunoglobulin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Normal Immunoglobulin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Human Normal Immunoglobulin Manufacturers, Product Type & Application
  7. 3.7 Global Human Normal Immunoglobulin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Normal Immunoglobulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Normal Immunoglobulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Normal Immunoglobulin Tier 1, Tier 2, and Tier 3
4 Human Normal Immunoglobulin Market by Type
  1. 4.1 Human Normal Immunoglobulin Type Introduction
  2. 4.1.1 Hepatitis B Immunoglobulins
  3. 4.1.2 Tetanus Immunoglobulins
  4. 4.1.3 Rabies Immunoglobulins
  5. 4.1.4 Others
  6. 4.2 Global Human Normal Immunoglobulin Sales by Type
  7. 4.2.1 Global Human Normal Immunoglobulin Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Human Normal Immunoglobulin Sales by Type (2021-2032)
  9. 4.2.3 Global Human Normal Immunoglobulin Sales Market Share by Type (2021-2032)
  10. 4.3 Global Human Normal Immunoglobulin Revenue by Type
  11. 4.3.1 Global Human Normal Immunoglobulin Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Human Normal Immunoglobulin Revenue by Type (2021-2032)
  13. 4.3.3 Global Human Normal Immunoglobulin Revenue Market Share by Type (2021-2032)
5 Human Normal Immunoglobulin Market by Application
  1. 5.1 Human Normal Immunoglobulin Application Introduction
  2. 5.1.1 Government Institutions
  3. 5.1.2 Private Sector
  4. 5.1.3 Other
  5. 5.2 Global Human Normal Immunoglobulin Sales by Application
  6. 5.2.1 Global Human Normal Immunoglobulin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Normal Immunoglobulin Sales by Application (2021-2032)
  8. 5.2.3 Global Human Normal Immunoglobulin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Human Normal Immunoglobulin Revenue by Application
  10. 5.3.1 Global Human Normal Immunoglobulin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Human Normal Immunoglobulin Revenue by Application (2021-2032)
  12. 5.3.3 Global Human Normal Immunoglobulin Revenue Market Share by Application (2021-2032)
6 Global Human Normal Immunoglobulin Sales by Region
  1. 6.1 Global Human Normal Immunoglobulin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Human Normal Immunoglobulin Sales by Region (2021-2032)
  3. 6.2.1 Global Human Normal Immunoglobulin Sales by Region (2021-2026)
  4. 6.2.2 Global Human Normal Immunoglobulin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Human Normal Immunoglobulin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Human Normal Immunoglobulin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Human Normal Immunoglobulin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Human Normal Immunoglobulin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Human Normal Immunoglobulin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Human Normal Immunoglobulin Revenue by Region
  1. 7.1 Global Human Normal Immunoglobulin Revenue by Region
  2. 7.1.1 Global Human Normal Immunoglobulin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Human Normal Immunoglobulin Revenue by Region (2021-2026)
  4. 7.1.3 Global Human Normal Immunoglobulin Revenue by Region (2027-2032)
  5. 7.1.4 Global Human Normal Immunoglobulin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Human Normal Immunoglobulin Revenue (2021-2032)
  8. 7.2.2 North America Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Human Normal Immunoglobulin Revenue (2021-2032)
  11. 7.3.2 Europe Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Human Normal Immunoglobulin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Human Normal Immunoglobulin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Human Normal Immunoglobulin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ADMA Biologics
  2. 8.1.1 ADMA Biologics Company Information
  3. 8.1.2 ADMA Biologics Business Overview
  4. 8.1.3 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ADMA Biologics Human Normal Immunoglobulin Product Portfolio
  6. 8.1.5 ADMA Biologics Recent Developments
  7. 8.2 Biotest
  8. 8.2.1 Biotest Company Information
  9. 8.2.2 Biotest Business Overview
  10. 8.2.3 Biotest Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Biotest Human Normal Immunoglobulin Product Portfolio
  12. 8.2.5 Biotest Recent Developments
  13. 8.3 CBPO
  14. 8.3.1 CBPO Company Information
  15. 8.3.2 CBPO Business Overview
  16. 8.3.3 CBPO Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CBPO Human Normal Immunoglobulin Product Portfolio
  18. 8.3.5 CBPO Recent Developments
  19. 8.4 CNBG
  20. 8.4.1 CNBG Company Information
  21. 8.4.2 CNBG Business Overview
  22. 8.4.3 CNBG Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CNBG Human Normal Immunoglobulin Product Portfolio
  24. 8.4.5 CNBG Recent Developments
  25. 8.5 CSL Behring
  26. 8.5.1 CSL Behring Company Information
  27. 8.5.2 CSL Behring Business Overview
  28. 8.5.3 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CSL Behring Human Normal Immunoglobulin Product Portfolio
  30. 8.5.5 CSL Behring Recent Developments
  31. 8.6 Emergent (Cangene)
  32. 8.6.1 Emergent (Cangene) Company Information
  33. 8.6.2 Emergent (Cangene) Business Overview
  34. 8.6.3 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Emergent (Cangene) Human Normal Immunoglobulin Product Portfolio
  36. 8.6.5 Emergent (Cangene) Recent Developments
  37. 8.7 Grifols
  38. 8.7.1 Grifols Company Information
  39. 8.7.2 Grifols Business Overview
  40. 8.7.3 Grifols Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Grifols Human Normal Immunoglobulin Product Portfolio
  42. 8.7.5 Grifols Recent Developments
  43. 8.8 Kamada
  44. 8.8.1 Kamada Company Information
  45. 8.8.2 Kamada Business Overview
  46. 8.8.3 Kamada Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kamada Human Normal Immunoglobulin Product Portfolio
  48. 8.8.5 Kamada Recent Developments
  49. 8.9 Kedrion
  50. 8.9.1 Kedrion Company Information
  51. 8.9.2 Kedrion Business Overview
  52. 8.9.3 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Kedrion Human Normal Immunoglobulin Product Portfolio
  54. 8.9.5 Kedrion Recent Developments
  55. 8.10 Hualan Bio
  56. 8.10.1 Hualan Bio Company Information
  57. 8.10.2 Hualan Bio Business Overview
  58. 8.10.3 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hualan Bio Human Normal Immunoglobulin Product Portfolio
  60. 8.10.5 Hualan Bio Recent Developments
  61. 8.11 Shanghai RAAS
  62. 8.11.1 Shanghai RAAS Company Information
  63. 8.11.2 Shanghai RAAS Business Overview
  64. 8.11.3 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai RAAS Human Normal Immunoglobulin Product Portfolio
  66. 8.11.5 Shanghai RAAS Recent Developments
  67. 8.12 Sichuan Yuanda Shuyang
  68. 8.12.1 Sichuan Yuanda Shuyang Company Information
  69. 8.12.2 Sichuan Yuanda Shuyang Business Overview
  70. 8.12.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Portfolio
  72. 8.12.5 Sichuan Yuanda Shuyang Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Human Normal Immunoglobulin Value Chain Analysis
  2. 9.1.1 Human Normal Immunoglobulin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Human Normal Immunoglobulin Production Mode & Process
  6. 9.2 Human Normal Immunoglobulin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Human Normal Immunoglobulin Distributors
  9. 9.2.3 Human Normal Immunoglobulin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst